Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes
Euna Cho, S M Bakhtiar Ul Islam, Fen Jiang, Ju-Eun Park, Bora Lee, Nam Deuk Kim, Tae-Ho Hwang
Cancer Res Treat. 2020;52(1):309-319.   Published online 2019 Aug 6     DOI: https://doi.org/10.4143/crt.2019.161
Citations to this article as recorded by Crossref logo
An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
Maryum Nisar, Rehan Zafar Paracha, Sidra Adil, Sumair Naseem Qureshi, Hussnain Ahmed Janjua
Frontiers in Oncology.2022;[Epub]     CrossRef
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
Seung Joon Lee, Hannah Yang, Woo Ram Kim, Yu Seong Lee, Won Suk Lee, So Jung Kong, Hye Jin Lee, Jeong Hun Kim, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim
Journal for ImmunoTherapy of Cancer.2021; 9(6): e002195.     CrossRef
Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
Tomoyoshi Inoue, Thomas Byrne, Mitsuko Inoue, Madeline E. Tait, Patrick Wall, Annabel Wang, Michael R. Dermyer, Hanane Laklai, Joseph J. Binder, Clare Lees, Robert Hollingsworth, Liliana Maruri-Avidal, David H. Kirn, Donald M. McDonald
Molecular Cancer Therapeutics.2021; 20(8): 1481.     CrossRef
Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
S. M. Bakhtiar Ul Islam, Bora Lee, Fen Jiang, Eung-Kyun Kim, Soon Cheol Ahn, Tae-Ho Hwang
Cancers.2020; 12(1): 228.     CrossRef